Achieve Life Sciences, Inc.
NASDAQ:ACHVBiotechnology
-$0.38 today
- Market cap
- $697.68M
- Beta
- 2.26
- P/E (TTM)
- -5.1
- EPS (TTM)
- -$0.97
Volume 1.09M
Average 1.44M
ACHV Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Achieve Life Sciences, Inc.NASDAQ: ACHV
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin not reported for Q1 FY2026
Sources:Income StatementText generated from reported figures; not investment advice.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How ACHV compares with its peers on the latest reported figures
No competitor Net Margin figures are available to compare.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 229K | 228K |
| Gross Profit | 0 | 0 | 0 | (229K) | (228K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 23.97M | 30.08M | 15.81M | 22.82M | 22.96M |
| Selling, General & Admin | 9.13M | 10.72M | 11.44M | 16.25M | 31.87M |
| Operating Expenses | 33.09M | 40.8M | 27.25M | 38.84M | 54.65M |
| Depreciation & Amortization | 250K | 236K | 228K | 229K | 228K |
| EBITDA | (32.9M) | (40.33M) | (26.73M) | (37.42M) | (53.6M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (33.09M) | (40.8M) | (27.25M) | (39.07M) | (54.88M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 17K | 199K | 825K | 2.36M | 1.5M |
| Interest Expense | 0 | 1.79M | 2.85M | 2.18M | 819K |
| Other Income / Expenses | (58K) | (1.55M) | (2.57M) | (758K) | 232K |
| Income Before Tax | (33.15M) | (42.35M) | (29.82M) | (39.83M) | (54.65M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (33.15M) | (42.35M) | (29.82M) | (39.83M) | (54.65M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) |
| EPS (Diluted) | (4.05) | (3.95) | (1.50) | (1.24) | (1.25) |
| Weighted Avg Shares | 8.12M | 10.59M | 19.83M | 32.07M | 43.59M |
| Weighted Avg Shares (Diluted) | 8.12M | 10.59M | 19.83M | 32.07M | 43.59M |
Achieve Life Sciences, Inc.
NASDAQ:ACHV
Intrinsic Alpha fair value
Locked
Current Price
$6.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.